PCSK9 and autoimmune disease: Future efforts should focus on developing safer, novel, and precision therapeutic strategies to target PCSK9, either independently or in conjunction with existing therapies for the treatment of CVDs, liver diseases, infections, autoimmune disorders, neurocognitive disorders, cancers, and etc.